RaltegravirIn Treatment-Naive Patients with HIV-1 Infection

被引：0
|
作者：
Jamie D. Croxtall
Lesley J. Scott
机构：
[1] Adis,
[2] a Wolters Kluwer Business,undefined
来源：
Drugs | 2010年 / 70卷
关键词：
Tenofovir; Efavirenz; Virological Failure; Raltegravir; Integrase Mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Raltegravir, a first-in-class, oral HIV type-1 (HIV-1) integrase inhibitor, blocks the covalent integration of HIV-1 complementary DNA into the host genome.
引用
收藏
页码：631 / 642
页数：11
相关论文
共 50 条
  • [21] Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China
    Yu, Fengting
    Li, Qun
    Wang, Linghang
    Zhao, Hongxin
    Wu, Hao
    Yang, Siyuan
    Tang, Yunxia
    Xiao, Jiang
    Zhang, Fujie
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2022, 15 : 195 - 203
  • [22] Human immunodeficiency virus (HIV) DNA load and level of immunosuppression in treatment-naive HIV-1 infected patients
    Riva, E
    Antonelli, G
    Scagnolari, C
    Pistello, M
    Capobianchi, MR
    Monforte, AD
    Pezzotti, P
    Dianzani, F
    JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (11): : 1826 - 1828
  • [23] Study of drug resistance among 78 antiretroviral treatment-naive patients with HIV-1 subtype B infection in central China
    Wang, Jing-Quan
    Huang, Xiao-Jie
    Zhang, Hong-Wei
    Li, Zai-Cun
    Wang, Xi-Cheng
    Li, Hai-Ying
    Shen, Cheng-Li
    Guo, Cai-Ping
    Wei, Fei-Li
    Zhang, Tong
    Wu, Hao
    DRUG DISCOVERIES AND THERAPEUTICS, 2007, 1 (02): : 86 - 88
  • [24] A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate
    De Clercq, Erik
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (17) : 2935 - 2937
  • [25] Genetic Diversity of HIV-1 Gene vif Among Treatment-Naive Brazilians
    Villanoval, Fabiola
    Barreiros, Marta
    Janini, Luiz Mario
    Diaz, Ricardo Sobhie
    Leal, Elcio
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2017, 33 (09) : 952 - 959
  • [26] Transmission of Dolutegravir resistance in treatment-naive individuals with HIV-1: A cohort study
    Pinto, Jorge Francisco da Cunha
    Gomes, Luiza Brito
    Melo, Natalia Dias
    de Souza, Fabiana Barbosa Assumpcao
    Freitas, Debora Viana
    Viega, Sara Gonzalez
    Nascimento, Erica Ramos dos Santos
    Boullosa, Lidia Theodoro
    Cardoso, Cynthia Chester
    Tanuri, Amilcar
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2025, 29 (02):
  • [27] HIV-1 Drug Resistance Among Treatment-Naive Transgenders from India
    Kurle, Swarali N.
    Kandaswami, Sudarshan
    Gadhe, Sharda
    Patil, Ajit
    Sarkar, Rohit
    Mehta, Sonal
    Gangakhedkar, Raman
    Arumugam, Viswanathan
    Chawla, Umesh
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (12) : 990 - 993
  • [28] Cost Effectiveness of Darunavir/ritonavir Combination Antiretroviral Therapy for Treatment-Naive Adults with HIV-1 Infection in Canada
    Brogan, Anita J.
    Smets, Erik
    Mauskopf, Josephine A.
    Manuel, Sarah A. L.
    Adriaenssen, Ines
    PHARMACOECONOMICS, 2014, 32 (09) : 903 - 917
  • [29] Cost Effectiveness of Darunavir/ritonavir Combination Antiretroviral Therapy for Treatment-Naive Adults with HIV-1 Infection in Canada
    Anita J. Brogan
    Erik Smets
    Josephine A. Mauskopf
    Sarah A. L. Manuel
    Ines Adriaenssen
    PharmacoEconomics, 2014, 32 : 903 - 917
  • [30] Antiretroviral pill count and clinical outcomes in treatment-naive patients with HIV infection
    Young, J.
    Smith, C.
    Teira, R.
    Reiss, P.
    Jarrin Vera, I.
    Crane, H.
    Miro, J. M.
    Monforte, A. D'Arminio
    Saag, M.
    Zangerle, R.
    Bucher, H. C.
    HIV MEDICINE, 2018, 19 (02) : 132 - 142
12345